The Otsuka Long-Evans Tokushima Fatty (OLETF) rat, serving as a spontaneously diabetic model with non-insulin-dependent diabetes mellitus (NIDDM), exhibits impaired glucose tolerance (IGT) at about 16 weeks of age. In this study, we investigated whether or not biotin, a water-soluble vitamin, improved the IGT of OLETF rats. To this end, we administered diets containing one of three levels of biotin, a high-biotin diet (BH), a normal-biotin diet (BN) and a basal-biotin diet (BB), to OLETF rats up to 24 weeks of age. An oral glucose tolerance test (OGTT) was performed four times between 13 and 22 weeks of age. The administration of a BH corrected the IGT of OLETF rats. Upon further investigation, we found that insulin secretion in the OLETF-BH rats was decreased to a significant extent, signaling that the hyperinsuline mia typical to the OLETF-BH rats had clearly improved. Body weights were significantly lower in the OLETF-BH group than in the other OLETF groups, even though the OLETF-BH rats showed a significantly higher average daily food intake. The body weight gain of the OLETF BH rats followed the same tendency as the control-LETO (Long Evans Tokushima Otsuka) rats (LETO-BB and LETO-BN). These results demonstrate that a high-level biotin diet can improve the glucose handicap in NIDDM rats. Key Words biotin, egg white, oral glucose tolerance test, NIDDM (non insulin-dependent diabetes mellitus), insulin secretion It has been found that biotin deficiency results in an impairment of glucose utilization (1-5).
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("diabetic KK mice") can be improved by feeding with a diet containing 2-4mg of biotin per kg for eight weeks, as shown by Raddi et al. (6) . Furthermore, they demonstrated that a pharmacologic dose of biotin (16mg/day for one week) lowered the plasma glucose concentration in insulin-dependent diabetic patients during insulin withdrawal. In clinical studies, we found (i) that the serum biotin levels in psoriasis vulgaris and pustulosis palmaris et plantaris (ppp) patients are significantly lower than in normal subjects and (ii) that the administration of biotin (9mg per day) to those patients can improve a variety of clinical symptoms as well as associated metabolic abnormalities (7) . Subsequently, we evaluated the thera peutic effectiveness of biotin in patients with non-insulin-dependent diabetes melli tus (NIDDM) and sternocostoclavicular hyperostosis (8, 9) . In a long-term experiment using Osteogenic Disorder Shionogi (ODS) rats, which have a hereditary defect in their ability to synthesize ascorbic acid and which were fed a biotin-deficient diet containing dried egg white and sufficient ascorbic acid, we observed a decrease in plasma insulin at an early stage of biotin deficiency (10) . The insulin secretion in response to an oral glucose load (1.8g glucose solution per kg body weight) in biotin-deficient Wistar male rats was approximately one-sixth less, in concentration terms, than that of pair-fed control rats (11) . However, the insulin content of the pancreas in the same biotin-deficient rats was no lower than that of the control rats. The reduction in insulin secretion of these biotin-deficient rats was significantly improved by the simultaneous administration of biotin (1mg per kg body weight) with the glucose solution (11) . Despite the accumulation of such reports, the metabolic mechanism underlying these effects remains unclear.
In this study, we used a new strain of rat (OLETF) with spontaneous persistent hyperglycemia in the absence of insulin therapy. In the chronic course of their diabetes mellitus, OLETF rats resemble humans with NIDDM (12) . This study aimed to establish (i) whether a relationship exists between biotin concentra tion and the extent of glucose tolerance, and (ii) whether biotin deficiency might be one of the factors contributing to impaired glucose tolerance in non-insulin dependent diabetic rats.
MATERIALS AND METHODS
Animals, diets and experimental design. Male OLETF and LETO rats were obtained from Tokushima Research Laboratories, Otsuka Pharmaceutical Co. Ltd. (Tokushima, Japan). The characteristic signs and features of the OLETF-strain rat are: 1) polyuria, polydipsia and mild obesity; 2) late onset hyperglycemia; 3) the chronic course of the disease; 4) inheritance by males; and 5) nervousness. We also used LETO rats as the control animal in this study. The LETO strain was obtained by different original matings from those for OLETF rats. Both strains originated from the same colony of Long-Evans rats. The LETO strain had not shown any signs of diabetes. Each rat was individually housed in a stainless-steel cage in an Vol. 42, No. 6, 1996 oral glucose tolerance during the nine-week experimental period. Subsequently, an OGTT was carried out on each rat in the third (1st OGTT), sixth (2nd OGTT) and ninth (3rd OGTT) week of the dietary regimens. An OGTT was performed without anaesthesia and the insulin secretion of each animal was measured four times over the nine-week experimental period. For this purpose, each animal was fasted for 24 h and the blood for glucose and insulin determination was collected from the tail vein before, and 30, 60, and 120 min after feeding of 1.8g glucose per kg body weight via a gastric catheter. The plasma glucose levels were estimated by a standard glucose oxidase method (14) (Glucose C-II test kit, Wako Pure Chemical Co. Ltd., Osaka, Japan). The immunoreactive insulin of the plasma was determined with a Shionogi Insulin RIA kit (Shionogi Co. Ltd., Osaka, Japan) which employs the double-antibody method of radioimmunoassay (15) . The diagnosis of diabetes mellitus involved the classification of the plasma glucose level by an OGTT (16) into one of the following three types: 1) normal pattern: <300mg/dl (at 30 min) and <200mg/dl (at 120 min); 2) impaired glucose tolerance (IGT) pattern:
either >300mg/dl (at 30 min) or >200mg/dl (at 120 min); and 3) diabetes mellitus (DM) pattern: both>300mg/dl (at 30 min) and >200mg/dl (at 120 min). Determination of biotin concentration in the plasma and organ. The plasma biotin concentration was determined microbiologically by a procedure described previously (13) . The test organism was Lactobacillus plantarum ATCC 8014. The samples of plasma and organ homogenates were acid-hydrolyzed prior to the assay.
Statistical analysis. All results are expressed as M•}SEM. A statistical analysis was performed by analysis of variance (ANOVA) coupled with Duncan's multiple-range test for classification of the means, with p<0.05 accepted as the level of significance.
RESULTS

Growth profiles and symptoms of OLETF and LETO rats
The growth curves for OLETF-BB, -BN and -BH rats and for LETO-BB and -BN rats are shown in Fig. 1 . At the start of the experiment using 13-week old rats, the average body weight of the OLETF rats was 400g and the LETO rats about 350g. All of the groups of OLETF rats grew at the same rate until 16 weeks old (the first three weeks of the dietary regimen). Thereafter, the OLETF-BH rats grew less than the other OLETF rats. After receiving their experimental diet for about 10 weeks, the average body weight of the OLETF-BH rats was significantly less than that of the OLETF-BB rats. Furthermore, the OLETF-BH rats grew at a rate similar to those of the LETO-BB and LETO-BN rats, with the exception of the difference in body weight at the start of the experiment. Glucose tolerance profile and plasma glucose level of OLETF and LETO rats Figure 2 depicts the plasma glucose levels in OLETF and LETO rats given 1.8 g of glucose solution per kg body weight by way of an oral tolerance test.The 13 week old OLETF rats had a glucose level similar to the LETO rats at 0 min. Nevertheless, the OLETF rats showed significantly higher plasma glucose levels than LETO rats at 30, 60 and 120 min after glucose loading. The plasma glucose levels of both the groups of 16-week old OLETF-BB and OLETF-BN rats exceeded 300mg/dl at 30 min, showing that they could be classified as having IGT. This continued until the end of the 22nd week of growth. However, the average plasma glucose levels of the OLETF-BH rats were significantly lower than those of the OLETF-BB and OLETF-BN rats at 30 and 60 min. Until the last experiment stage (22 weeks old), the pattern of the OLETF-BH rats was similar to that of other OLETF rats shown after glucose loading at 13 weeks of age. This tendency was even more prominent in the sixth and ninth weeks on the experimental diet. Biotin did not alter plasma glucose levels in control-LETO rats (LETO-BB and LETO BN) after glucose loading during the nine-week experimental period. Effect fect of dietary biotin level on insulin response to an oral glucose load inOLETF and LETO rats As shown in Fig. 2 , before beginning the three kinds of experimental diet (rats at 13 weeks of age), the LETO rats showed significantly higher insulin levels at 30 min after glucose loading. The average insulin level of the OLETF-BH group of 16 week old rats was a lower value than the other OLETF groups, but it was not H. ZHANG et al. significantly different. The levels did not become significantly different from each other during the 120 min after glucose loading. However, the insulin response pattern of the OLETF-BH rats at 19 weeks of age began to show a significant downward shift as compared to the pattern for the OLETF-BB and OLETF-BN rats. The difference was even more significant, the insulin level for the OLETF-BH rats at 22 weeks of age at 30, 60 and 120 min were 47, 43 and 37%, respectively, when comparing only the OLETF-BB group (Fig. 2) . Overall, the insulin secretion in response to the oral glucose loading of OLETF-BH rats was approximately 50% less, in concentration terms, than that of OLETF-BB rats. Specifically, the insulin concentration at each of the four time points (0, 30, 60 and 120 min) in the last experimental stage (after nine weeks on an experimental diet) was significantly reduced by the addition of excess biotin into the diet. Biotin did not alter plasma insulin concentrations in the control-LETO rats (LETO-BB and LETO-BN) after glucose loading during the nine-week exper Biotin content of plasma and organ in OLETF and LETO rats The plasma biotin concentrations determined at various ages (13, 16, 19 and 22 weeks) are shown in Table 2 . OLETF rats 13 weeks of age had a significantly higher concentrations of biotin in their plasma than did the LETO rats. However, throughout the nine-week experimental period, the plasma biotin concentrations of OLETF-BH rats did not rise to a higher level than those of the OLETF-BB rats. As shown in Table 3 , the concentrations of biotin in the liver and pancreas of rats in the OLETF-BH group were significantly higher than the other groups of OLETF BB and OLETF-BN. Nevertheless, the LETO rats (LETO-BB and LETO-BN) showed extremely high levels of biotin in the liver and pancreas. Moreover, the average weight of the pancreas of LETO rats was significantly heavier than that of the OLETF rats, but the average weights of the liver and pancreas were not significantly difference among three groups of OLETF rats (Table 3) .
DISCUSSION
The effect of dietary biotin intake on plasma glucose concentration and insulin secretion was investigated in OLETF and LETO rats using an oral glucose tolerance test (OGTT). The OLETF-BB rats showed a characteristic pattern of IGT. However, when the diet was supplemented with a high level of biotin, the plasma glucose level in the OLETF-BH rats became within the normal range before the end of the study (at 22 weeks of age); the improvement was increasingly apparent as the experiment progressed. In the case of NIDDM mice (KK mice) with moderate hyperglycemia (glucose levels remaining at 150-250mg/dl), the high doses of biotin (2 or 4mg/kg) administered were remarkably potent in lowering the blood glucose concentration, and improved their IGT. The biotin concentration did not increase in the blood of KK mice treated with biotin (6) . This result is the same as that for the OLETF rats used in this study. In addition, a high-level biotin diet improved the hyperinsulinemic secretion in OLETF rats (Fig. 2) . Nevertheless, the serum immunoreactive insulin levels after glucose loading did not decrease in biotin-treated KK mice.
In our previous study, the reduction of insulin secretion in biotin-deficient rats was significantly improved by the simultaneous administration of biotin and a glucose solution (11) . Berdanier and Marshall (17) suggested that biotin may serve to enhance the synthesis or release of insulin in male adult rats. From these previous results, it was believed that biotin may affect the efficiency with which insulin operates in the glucose metabolism, perhaps by some action at the level of insulin secretion. In this experiment, however, the insulin concentration in the plasma of the OLETF-BH rats was rather diminished (Fig. 2) . This result indicates that a dietary high biotin intake can improve the metabolism or/and utilization of glucose without the acceleration of insulin secretion from the pancreas.
In this study, the obesity characteristic to the OLETF rat was clearly seen, and the extent of the body weight gain was negatively correlated with the biotin level in the diet. Nevertheless, a subsequent measurement of the food intake of LETO and OLETF rats at 24 weeks of age showed that the OLETF-BH group had a significantly greater food intake than the OLETF-BB rats (p<0.01) (Fig. 3) . These results demostrate that the diet requirement of the OLETF-BH rats im proved due to the administration of a high level of biotin.
The mechanisms of improving IGT and decreasing body weight gain by biotin administration via a diet are still unclear, but we can speculate as follows: Li Hsieh and Mistry (18) pointed out that the activity of glucokinase is low in diabetic, fasting and biotin-deficient rats, and that de novo synthesis of the enzyme could be induced by insulin and biotin in intact rat liver. Furthermore, biotin can regulate the glucokinase gene at the transcriptional stage in the liver of fasted rat (19 
